ISSN: 1099-5129

Journal Home

Journal Guideline

Europace Q1 Unclaimed

Oxford University Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Europace is a journal indexed in SJR in Physiology (medical) and Cardiology and Cardiovascular Medicine with an H index of 119. It has an SJR impact factor of 1,899 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,899.

Europace focuses its scope in these topics and keywords: atrial, fibrillation, pulmonary, cardiac, multicentre, study, isolation, left, ablation, clinical, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q1) Physiology (medical) (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,899

SJR Impact factor

119

H Index

261

Total Docs (Last Year)

1045

Total Docs (3 years)

4073

Total Refs

3572

Total Cites (3 years)

716

Citable Docs (3 years)

3.51

Cites/Doc (2 years)

15.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Circulation Q1
Nature Metabolism Q1
Sleep Medicine Reviews Q1
Circulation: Arrhythmia and Electrophysiology Q1
JACC: Clinical Electrophysiology Q1

Compare this journals

Aims and Scope

Best articles by citations

Impaired arterial baroreceptor sensitivity before tilt-induced syncope

Ice mapping during cryothermal ablation of accessory pathways in WPW: the role of the temperature time constant

Detection by intracardiac echocardiography of early formation of left atrial thrombus during pulmonary vein isolation

Clinical value of routine predischarge testing after ICD-implantation

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy

Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure -ATLAS score

A01-1 Adenosine-induced syncope: Prevalence and characteristics

A01-2 Detecting baroreflex activity by a sequential analysis during head-up tilt test in young women with syncope

42Atrial fibrillation ablation as a day-case procedure: three-year single-centre experience

A01-3 The effect of beta-blockers on the central serotonergic responsivity, in patients with neurocardiogenic syncope

A01-4 Response to head-up tilt testing and follow-up in patients with situational syncope; Comparison with vasovagal syncope

SHOW MORE ARTICLES

A01-5 Long-term follow-up in patients with vasovagal syncope

A01-6 The application of a programme of home-based tilt ? trainig in patients suffering from vasovagal syncope

A02-1 Incidence of cerebral embolism in high risk patients with atrial fibrillation

A02-2 Atrial fibrillation and thrombus formation: Time depended or genetic disorders?

A02-3 Conversion of atrial fibrillationto sinus rhythm could induce hyperclotting state: The relationship with the atrial fibrillation duration

A02-4 Incidence of cerebral embolism in patients with atrial fibrillation and cardioversion

A02-5 Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins

A02-6 New automatic diagnostic functions for quantification of atrial arrhythmias in pacemaker patients

A03-1 Long-term clinical outcome and device performance of biventricular pacing: A single center evaluation from three-year follow-up of consecutive heart failure patients

A03-2 Cost-effectiveness analysis of biventricular pacing

A03-3 Prediction of clinical response to cardiac resynchronization therapy by QRS duration and shortening

A03-5 Cardiac resynchronisation therapy allows medical therapy optimization in patients with advanced congestive heart failure? Results of the insync/insyncicd Italian registries